Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL

Blood

Volumn 97, Issue 5, 2001, Pages 1442-1450

  Li, Shaoguang ^b   Gillessen, Silke ^b   Tomasson, Michael H ^b   Dranoff, Glenn ^b   Gilliland, D Gary ^b   Van Etten, Richard A ^a  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEMATOPOIETIC STEM CELL; LEUKEMOGENESIS; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0035282909     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1442     Document Type: Article

References (36)

1. Chronic myeloid leukemia
2. The biology of chronic myeloid leukemia
3. The bcr-abl oncogene transforms rat-1 cells and cooperates with v-myc
4. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein
5. In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the Philadelphia chromosome
6. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
7. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
8. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
9. Bcr-Abl with an SH3 deletion retains the ability to induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy
10. The Grb2 binding site is required for induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase
11. Marrow colony stimulating activity in chronic myelogenous leukemia
12. Levels of serum granulocyte colony-stimulating factor in patients with chronic myeloid leukemia
13. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia
14. Cytokine manipulation of primitive human hematopoietic cell self-renewal
15. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells
16. BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
17. bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia
18. bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hematopoietic neoplasms in mice
19. Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder
20. Involvement of interleukin-3 in delayed-type hypersensitivity
21. Role for interleukin-3 in mast cell and basophil development and in immunity to parasites
22. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
23. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
24. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
25. Versatile retroviral vectors for potential use in gene therapy
26. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
27. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
28. Induction of myeloproliferative disease in mice by TEL tyrosine kinase fusion oncogenes does not require GM-CSF or IL-3
29. Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer
30. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myeloid- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion gene
31. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
32. Leukemia in atomic bomb survivors: I, general observations
33. Duration of the preclinical phase of chronic myelogenous leukemia: A case report
34. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia
35. STAT5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
36. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization